Rx Medical Food Market Recent Major Trend & Industry Challenges with High Growth CAGR of 6.8% by 2027

Rx Medical Food Market – Insights

Medical food is used as supportive therapy and for diet management during the treatment of a specific disease or medical condition such as pulmonary and metabolic disorders. Medical foods contain ingredients that have recognized as safe (GRAS) status, a status that is assigned to naturally found food ingredients. The characteristics of medical food vary from those of dietary supplements, prescription drugs, and nutritional food. Medical food contains protein, nutrients such as omega 3 fatty acids, chelated zinc, and isoflavones, minerals, and vitamins such as folic acid and thiamine. Physicians prescribe medical foods or a patient can consume such food under their supervision.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/909

According to the U.S. Food and Drug Administration (FDA), there are four types of medical foods such as nutritional complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The medical food category is separately regulated by the U.S. FDA under Orphan Drug Act (1988). The regulation restricts marketing of products that falsely claim to cure medical conditions in order to ensure safety of the populace. Manufacturers of medical food do not need to get premarket approval, specification as an Investigational New Drug (IND), and individual registration with the FDA for product launch. However, manufacturers need to conduct proper laboratory and clinical studies that prove the health claims associated with the medical food.

Rx Medical Food Market – Drivers

Increasing awareness regarding benefits of medical food is augmenting growth of the Rx medical food market. Moreover, favorable regulatory scenario is also expected to boost the market growth over the forecast period. For instance, in 2013, the U.S. FDA amended regulations related to formulation and marketing of medical food, the category that was previously ill-defined. The amendment made clear some issues associated with marketing and branding of medical food products. According to the U.S. FDA, no prescription is required to buy medical foods. However, such foods should be consumed under a physician’s supervision.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/909

Key players in the market such as Nestlé and Danone are focused on investment in R&D to expand their product portfolio for chronic pain and personalized medicine. Axona (Accera), Limbrel, Deplin, Lofenalac, Ensure, Vasculera, and Vascazen are some of the medical food currently available in the market.

The global Rx medical food market was valued at US$ 19,387.3 million in 2020 and is expected to witness a robust CAGR of 6.8% over the forecast period (2020-2027).

Figure 1. Global Rx Medical Food Market by Region-2016 (US$ Mn)

Source: Coherent Market Insights Analysis (2017)

Rx Medical Food Market – Regional Analysis

On the basis of region, the global medical food market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The market in North America is expected to account for the largest market share over the forecast period, followed by Europe and Asia Pacific. Clarified definition of medical food category by regulatory bodies in North America and Europe is aiding in growth of the market. The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry in the U.S., announced to explore and include medical food as part of its mission, in 2017. The CRN will provide a common platform for major players in the industry to work together towards the advancement of medical food and to increase awareness about medical food among healthcare practitioners and consumers. Moreover, key players in the market are focused on investing in R&D to expand their product portfolio. For instance, Nestlé set out a US$ 500 Mn budget to support medical food research by 2021.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/rx-medical-food-market-to-surpass-us-264557-million-threshold-by-2025-globally-on-account-of-increasing-regulatory-support-379

Increasing focus of regulatory bodies in Australia and New Zealand to clearly define medical food category   is also expected to boost the market growth. For instance, in Australia and New Zealand, medical food is regulated under Food Standards Code 2.9.5. Such scenario is expected to boost growth of the market in Asia Pacific.

Major players operating in the Rx medical food market include Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., and Pivotal Therapeutics.

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By Therapeutic Application
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Market Trends
   • Impact Analysis
   • Key Development
   • Regulatory Scenario
   • Pest Analysis
   • Medical Foods Insurance Coverage
   • Reimbursement Scenario
   • Product Cannibalization Studies
   • Pricing Analysis of Major Products
   • Prescription Pattern Of Medical Foods (Disease Areas)
   • Physician Perspective And Patient Perspective On Rx Medical Foods
   • Packaging And labelling Requirements
   • Brand Analysis (Capsules, Liquid, Tablets and powder)
4. Rx Medical Food Market – Impact of Coronavirus (Covid-19) Pandemic
   • Pre COVID Impact
   • Post COVID Impact
   • Overall Impact On The Healthcare Industry
   • Key Developments
5. Global Rx Medical Food Market, By Product Type, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Pills
   • Powder
   • Liquid
   • Others (Wafers, Chewable, Bars)
6. Global Rx Medical Food Market , By Therapeutic Application, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Pain Management
   • Sleep Disorder
   • Neurological Disorder
   • GI Disorder
   • Pulmonary Disorder
   • Metabolic Disorder
   • Metabolic Disorder
7. Global Rx Medical Food Market , By Distribution Channel, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Retail Pharmacies
   • Online Pharmacies
8. Global Rx Medical Food Market , By Region, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, By Region, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, By Region, 2017 – 2027
     • Regional Trends
   • North America
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • China
       • Japan
       • India
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
       • North Africa
       • Central Africa
       • South Africa
9. Competitive Landscape
   • Company Profiles
     • Abbott Laboratories
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Strategies
     • Danone S.A.
     • Mead Johnson & Company, LLC.
     • Fresenius Kabi AG
     • Nestle S.A.
     • Primus Pharmaceuticals, Inc.
     • Targeted Medical Pharma Inc.
     • Pivotal Therapeutics Inc.
     • VAYA Pharma, Inc.
     • AlfaSigma S.P.A.
10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837